and eplerenone is selective to the aldosterone receptor. Although numerous clinical trials have evaluated the efficacy of each drug, no studies have directly compared spironolactone and eplerenone.

Baxdrostat is a drug that reduces aldosterone levels in the body to treat high blood pressure and other conditions. It's an ...

High blood pressure, or hypertension, affects more than 1.5 billion people worldwide and is a major cause of heart disease ...

RADNOR, Pa. - Mineralys Therapeutics , Inc. (NASDAQ:MLYS), a biopharmaceutical company specializing in the development of treatments for cardiovascular and kidney diseases, has announced the ...

Preliminary studies designed to investigate the possible role of angiotensin in the marked oversecretion of aldosterone found in cirrhosis have been reported. It has been observed that patients with ...

and other diseases driven by dysregulated aldosterone, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) Application for a ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS) has announced the completion of enrollment for its Explore-CKD Phase 2 trial. The ...

The validity as well as the usefulness of measuring components of the renin-angiotensin-aldosterone system in ... lower BP in a timely manner with fewer drugs. [1] Additionally, curable forms ...

Meyer et al 1 provide data to suggest that patients with classical histopathology had a greater degree of contralateral suppression of aldosterone production on AVS than those with nonclassical ...

The biotech industry’s DeepSeek moment came last fall.

After hours: February 7 at 7:33:13 PM EST Loading Chart for DRUG ...

Drug addiction is a condition in which there is uncontrolled use of a substance with a harmful outcome. Drugs overstimulate the brain’s reward circuit, producing pleasure or euphoria. With repeated ...